Red X iconGreen tick iconYellow tick icon
Sun striking the ClocktowerWednesday 13 January 2016 8:41am

Allan Herbison image
Professor Allan Herbison

University of Otago researchers are part of an international team of scientists who have discovered how anti-Müllerian hormone (AMH) may act in the brain to cause polycystic ovary syndrome (PCOS) symptoms.

Around 10 per cent of women of childbearing age have PCOS, making it the most common reproductive disorder in females. Many women with PCOS are infertile.

AMH levels in the blood of women with PCOS are known to be two to three times higher than in other women, but how AMH may cause or worsen symptoms has remained unclear.

Now, a team including Otago scientists Professor Allan Herbison and Dr Rebecca Campbell and their research groups have discovered that AMH, which is produced in the ovary, acts in the brain to overexcite the neurons that control ovarian function.

Through a series of experiments, the researchers determined that gonadotropin-releasing hormone (GnRH) neurons have receptors for AMH and that AMH potently activates the firing of these neurons.

They then showed that the overactive GnRH neurons prompted the pituitary gland to release more frequent pulses of luteinising hormone into the bloodstream.

Professor Herbison says that these higher frequency pulses result in abnormal ovarian function, including the development of ovarian cysts and elevated production of androgens, which are both cardinal features of the syndrome.

“This research suggests that reducing AMH concentrations in PCOS women to normal levels may bring their ovarian function, including fertility, back to normal,” he says.

AMH is a hormone that until recent years was thought only to have an important role in the development of the reproductive anatomy of male embryos. Scientists have now discovered that it appears to play previously unsuspected roles in a number of neural networks.

“Now we can add brain control of fertility to that list of networks,” Professor Herbison says.

The research, which is newly published in the leading journal Nature Communications, was supported by funding from the Health Research Council of New Zealand.

For more information, contact:

Dr Rebecca Campbell
Centre for Neuroendocrinology and Department of Physiology
University of Otago
Tel: 64 3 479 7343
Email: rebecca.campbell@otago.ac.nz

Professor Allan Herbison
Centre for Neuroendocrinology and Department of Physiology
University of Otago
Email: allan.herbison@otago.ac.nz

Publication details:

Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion
Irene Cimino, Filippo Casoni, Xinhuai Liu, Andrea Messina, Jyoti Parkash, Soazik P. Jamin, Sophie Catteau-Jonard, Francis Collier, Marc Baroncini, Didier Dewailly, Pascal Pigny, Mel Prescott, Rebecca Campbell, Allan E. Herbison, Vincent Prevot, & Paolo Giacobini
Nature Communications, DOI: 10.1038/ncomms10055

A list of Otago experts available for media comment is available elsewhere on this website.

Electronic addresses (including email accounts, instant messaging services, or telephone accounts) published on this page are for the sole purpose of contact with the individuals concerned, in their capacity as officers, employees or students of the University of Otago, or their respective organisation. Publication of any such electronic address is not to be taken as consent to receive unsolicited commercial electronic messages by the address holder.
Back to top